Literature DB >> 14592755

Genetic and phylogenetic characterization of the type II cyclobutane pyrimidine dimer photolyases encoded by Leporipoxviruses.

C James Bennett1, Melissa Webb, David O Willer, David H Evans.   

Abstract

Shope fibroma virus and myxoma virus encode proteins predicted to be Type II photolyases. These are enzymes that catalyze light-dependent repair of cyclobutane pyrimidine dimers (CPDs). When the Shope fibroma virus S127L gene was expressed in an Escherichia coli strain lacking functional CPD repair pathways, the expressed gene protected the bacteria from 70-75% of the ultraviolet (UV) light-induced cytotoxic DNA damage. This proportion suggests that Leporipoxvirus photolyases can only repair CPDs, which typically comprise approximately 70% of the damage caused by short wavelength UV light. To test whether these enzymes can protect virus genomes from UV, we exposed virus suspensions to UV-C light followed by graded exposure to filtered visible light. Viruses encoding a deletion of the putative photolyase gene were unable to photoreactivate UV damage while this treatment again eliminated 70-90% of the lethal photoproducts in wild-type viruses. Western blotting detected photolyase protein in extracts prepared from purified virions and it can be deduced that the poxvirion interior must be fluid enough to permit diffusion of this approximately 50-kDa DNA-binding protein to the sites where it catalyzes photoreactivation. Photolyase promoters are difficult to categorize using bioinformatics methods, as they do not obviously resemble any of the known poxvirus promoter motifs. By fusing the SFV promoter to DNA encoding a luciferase open reading frame, the photolyase promoter was found to exhibit very weak late promoter activity. These data show that the genomes of Leporipoxviruses, similar to that of fowlpox virus, encode catalytically active photolyases. Phylogenetic studies also confirmed the monophyletic origin of poxviruses and suggest an ancient origin for these genes and perhaps poxviruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592755     DOI: 10.1016/s0042-6822(03)00512-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Tumorigenic poxviruses up-regulate intracellular superoxide to inhibit apoptosis and promote cell proliferation.

Authors:  Melissa L T Teoh; Patricia V Turner; David H Evans
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

Review 3.  Physiology, Biochemistry, and Applications of F420- and Fo-Dependent Redox Reactions.

Authors:  Chris Greening; F Hafna Ahmed; A Elaaf Mohamed; Brendon M Lee; Gunjan Pandey; Andrew C Warden; Colin Scott; John G Oakeshott; Matthew C Taylor; Colin J Jackson
Journal:  Microbiol Mol Biol Rev       Date:  2016-04-27       Impact factor: 11.056

4.  Vaccinia Virus Gene Acquisition through Nonhomologous Recombination.

Authors:  Greg Vallée; Peter Norris; Patrick Paszkowski; Ryan S Noyce; David H Evans
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

5.  DNA photolyase from Antarctic marine bacterium Rhodococcus sp. NJ-530 can repair DNA damage caused by ultraviolet.

Authors:  Yingying He; Changfeng Qu; Liping Zhang; Jinlai Miao
Journal:  3 Biotech       Date:  2021-01-29       Impact factor: 2.406

Review 6.  The current status and future directions of myxoma virus, a master in immune evasion.

Authors:  Bart Spiesschaert; Grant McFadden; Katleen Hermans; Hans Nauwynck; Gerlinde R Van de Walle
Journal:  Vet Res       Date:  2011-06-09       Impact factor: 3.683

7.  Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.

Authors:  Chad R Irwin; Nicole A Favis; Kate C Agopsowicz; Mary M Hitt; David H Evans
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Live-Cell Imaging of Vaccinia Virus Recombination.

Authors:  Patrick Paszkowski; Ryan S Noyce; David H Evans
Journal:  PLoS Pathog       Date:  2016-08-15       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.